SPR741, an antibiotic adjuvant, potentiates the in vitro and in vivo activity of rifampin against clinically relevant XDR- Acinetobacter baumannii
Zurawski, Daniel V., Reinhart, Alexandria A., Alamneh, Yonas A., Pucci, Michael J., Si, Yuanzheng, Abu-Taleb, Rania, Shearer, Jonathan P., Demons, Samandra T., Tyner, Stuart D., Lister, TroyLanguage:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/aac.01239-17
Date:
September, 2017
File:
PDF, 1.26 MB
english, 2017